Skip to content
Triangle logo TriangleGet started
← Full study record

NCT03361748 · OUTCOME

Number of Participants With Safety Related Events

Efficacy and Safety Study of bb2121 in Subjects With Relapsed and Refractory Multiple Myeloma · Source last updated 2025-05-23

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
COUNT_OF_PARTICIPANTS
Unit
Participants
Interval / dispersion
Not reported
Time frame
From screening to the end of follow up (approximately 5 years and 2 months)

What was measured

Number of participants with adverse events (AEs), adverse events of special interest (AESI), serious adverse events (SAEs), cytokine release syndrome, neurotoxicity, infection and clinically signifcant laboratory abnormalities.

Analysis population: All Treated Participants

Groups in this outcome

BB2121

BB2121

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
BB2121137

Reported measurements

Any Grade AE
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
BB2121137Not reportedNot reportedNot reportedNot reported
Grade 3 or 4 AE
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
BB2121136Not reportedNot reportedNot reportedNot reported
SAEs
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
BB212198Not reportedNot reportedNot reportedNot reported
AEs of Special Interest
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
BB2121136Not reportedNot reportedNot reportedNot reported
Cytokine Release Syndrome
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
BB2121116Not reportedNot reportedNot reportedNot reported
Neurotoxicity
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
BB212153Not reportedNot reportedNot reportedNot reported
Infections
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
BB212195Not reportedNot reportedNot reportedNot reported
Clinically Significant Laboratory Abnormalities
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
BB21210Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        137
    title
    Any Grade AE
  2. categories
    1. measurements
      1. group Id
        OG000
        value
        136
    title
    Grade 3 or 4 AE
  3. categories
    1. measurements
      1. group Id
        OG000
        value
        98
    title
    SAEs
  4. categories
    1. measurements
      1. group Id
        OG000
        value
        136
    title
    AEs of Special Interest
  5. categories
    1. measurements
      1. group Id
        OG000
        value
        116
    title
    Cytokine Release Syndrome
  6. categories
    1. measurements
      1. group Id
        OG000
        value
        53
    title
    Neurotoxicity
  7. categories
    1. measurements
      1. group Id
        OG000
        value
        95
    title
    Infections
  8. categories
    1. measurements
      1. group Id
        OG000
        value
        0
    title
    Clinically Significant Laboratory Abnormalities
denoms
  1. counts
    1. group Id
      OG000
      value
      137
    units
    Participants
description
Number of participants with adverse events (AEs), adverse events of special interest (AESI), serious adverse events (SAEs), cytokine release syndrome, neurotoxicity, infection and clinically signifcant laboratory abnormalities.
groups
  1. description
    BB2121
    id
    OG000
    title
    BB2121
param Type
COUNT_OF_PARTICIPANTS
population Description
All Treated Participants
reporting Status
POSTED
time Frame
From screening to the end of follow up (approximately 5 years and 2 months)
title
Number of Participants With Safety Related Events
type
SECONDARY
unit Of Measure
Participants

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice